Litcius/Paper detail

SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response

Michael Bonelli, Daniel Mrak, Thomas Perkmann, Helmuth Haslacher, Daniel Aletaha

2021Annals of the Rheumatic Diseases154 citationsDOI

Topics & Concepts

MedicineMinor strokeStroke (engine)RituximabAuditVaccinationPediatricsOutpatient clinicInternal medicineEmergency medicinePhysical therapyImmunologyLymphomaMechanical engineeringEngineeringManagementStenosisEconomicsSARS-CoV-2 and COVID-19 ResearchRetinal and Optic ConditionsHeparin-Induced Thrombocytopenia and Thrombosis
SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response | Litcius